Credit Suisse’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-14,866,267
| Closed | -$10.3M | – | 3696 |
|
|
2020
Q4 | $10.3M | Sell |
14,866,267
-6,714,587
| -31% | -$4.63M | 0.01% | 1113 |
|
|
2020
Q3 | $48.6M | Buy |
21,580,854
+1,959,371
| +10% | +$4.41M | 0.03% | 439 |
|
|
2020
Q2 | $70.2M | Buy |
19,621,483
+644,297
| +3% | +$2.31M | 0.05% | 309 |
|
|
2020
Q1 | $72.1M | Buy |
18,977,186
+202,288
| +1% | +$769K | 0.06% | 245 |
|
|
2019
Q4 | $56.5M | Buy |
+18,774,898
| New | +$56.5M | 0.04% | 365 |
|